EMA evaluating J&J's booster shot application

Monday, 22. November 2021 14:42

The European Medicines Agency (EMA) announced on Monday that it has started evaluating an application by Johnson & Johnson for the use of booster doses of the company's COVID-19 vaccine. If approved, the booster would be available at least two months after the first dose of the single-dose vaccine.

The EMA stated the assessment will take into consideration data from a study involving more than 14,000 adults. The outcome of the evaluation is expected "within weeks," unless additional information is needed. The United States Food and Drugs Administration authorized the shot last month.

Related Links: Johnson & Johnson
Baha Breaking the News (BBN) / DJ